Recent oral contraceptive use and adverse birth outcomes

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 144, Issue 1, 2009, Pages 40-43

  Chen, Xi Kuan ^a,b   Wen, Shi Wu ^b   Sun, Lu Ming ^b,c   Yang, Qiuying ^b   Walker, Mark C ^b   Krewski, Daniel ^a,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Shanghai First Maternity and Infant Health Hospital   (China)

^d RISK SCIENCES INTERNATIONAL   (Canada)

Author keywords

Birth outcomes; Low birth weight; Oral contraceptives; Preterm birth

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; EXPOSURE VARIABLE; FEMALE; HIGH BIRTH WEIGHT; HUMAN; LAST MENSTRUAL PERIOD; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; MENSTRUAL CYCLE; PARITY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; PROLONGED PREGNANCY; RISK ASSESSMENT; VERY LOW BIRTH WEIGHT;

EID: 64149092811     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.12.016     Document Type: Article

References (19)

1. Kost K., Singh S., Vaughan B., Trussell J., and Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77 1 (2008) 10-21
2. Black A., Francoeur D., Rowe T., et al. Canadian contraception consensus. J Obstet Gynaecol Can 26 2 (2004) 143-174
3. Kasan P.N., and Andrews J. Oral contraception and congenital abnormalities. Br J Obstet Gynaecol 87 7 (1980) 545-551
4. Harlap S., Shiono P.H., and Ramcharan S. Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception. Int J Fertil 30 2 (1985) 39-47
5. Janerich D.T., Piper J.M., and Glebatis D.M. Oral contraceptives and birth defects. Am J Epidemiol 112 1 (1980) 73-79
6. Kasan P.N., and Andrews J. The effects of recent oral contraceptive use on the outcome of pregnancy. Eur J Obstet Gynecol Reprod Biol 22 1-2 (1986) 77-83
7. Kricker A., Elliott J.W., Forrest J.M., and McCredie J. Congenital limb reduction deformities and use of oral contraceptives. Am J Obstet Gynecol 155 5 (1986) 1072-1078
8. Martinez-Frias M.L., Bermejo E., Rodriguez-Pinilla E., and Prieto L. Periconceptional exposure to contraceptive pills and risk for Down syndrome. J Perinatol 21 5 (2001) 288-292
9. Ericson A., Kallen B., and Lindsten J. Lack of correlation between contraceptive pills and Down's syndrome. Acta Obstet Gynecol Scand 62 5 (1983) 511-514
10. Bracken M.B. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 76 3 Pt 2 (1990) 552-557
11. Pardthaisong T., Gray R.H., McDaniel E.B., and Chandacham A. Steroid contraceptive use and pregnancy outcome. Teratology 38 1 (1988) 51-58
12. Mucci L.A., Lagiou P., Hsieh C.C., et al. A prospective study of pregravid oral contraceptive use in relation to fetal growth. BJOG 111 9 (2004) 989-995
13. Polednak A.P., Janerich D.T., and Glebatis D.M. Maternal exposure to exogenous sex hormones in relation to birth weight of offspring. Teratology 27 2 (1983) 223-229
14. Stergachis A., Saunders K.W., Davis R.L., et al. Examples of automated databases. In: Strom B.L., and Kimmel S.E. (Eds). Texbooks of pharmacoepidemiology (2006), John Wiley & Sons Ltd, Philadephia 173-214
15. Von Kroff M., Wagner E.H., and Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 45 2 (1992) 197-203
16. Pardthaisong T., and Gray R.H. In utero exposure to steroid contraceptives and outcome of pregnancy. Am J Epidemiol 134 8 (1991) 795-803
17. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott Raven
18. Yasuda Y., Kihara T., and Nishimura H. Effect of ethinyl estradiol on development of mouse fetuses. Teratology 23 2 (1981) 233-239
19. Berenson A.B., Wiemann C.M., Rowe T.F., and Rickert V.I. Inadequate weight gain among pregnant adolescents: risk factors and relationship to infant birth weight. Am J Obstet Gynecol 176 6 (1997) 1220-1224